Use of quinones in brain-tumor therapy: Preliminary results of preclinical laboratory investigations

Journal of Toxicology and Environmental Health

Volumn 16, Issue 5, 1985, Pages 713-719

  Berger, Mitchel S ^a   Talcott, Ronald E ^a   Rosenblum, Mark L ^a   Silva, Marilyn ^b   Aliosman, Francis ^a   Smith, Martyn T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2,3 BIS(BROMOMETHYL) 1,4 NAPHTHOQUINONE; CARMUSTINE; DICOUMAROL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; BONE MARROW CELL; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CYTOTOXICITY; DRUG THERAPY; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLIC ACTIVATION; PRIORITY JOURNAL; THERAPY; TUMOR CELL;

ANIMALS; BONE MARROW CELLS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL SURVIVAL; CELLS, CULTURED; DICUMAROL; GLIOMA; HUMANS; MICE; NAD(P)H DEHYDROGENASE (QUINONE); QUINONE REDUCTASES; QUINONES; RATS;

MURINAE;

EID: 0022295376     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/15287398509530781     Document Type: Article

References (17)

1. AliOsman, F., Giblin, J., and Rosenblum, M. L. 1983. Development of clonal and macromolecular synthesis assays for bone marrow CFU-GM to measure myelotoxicity of selected chemotherapeutic agents. Proc. V Conf. Brain Tumor Res., Asilomar, Calif., 1983, Abstract 2.
2. Cosby, L. A., Pardini, R. S., Biagini, R. E., Lambert, T. L., Lin, A. J., Huang, Y.-M., Hwang, K. M., and Sartorelli, A. C. 1976. Mode of action of the bioreductive alkylating agent 2,3-bis (chloromethyl)- 1,4-naphthoquinone. Cancer Res. 36:4023-4031.
3. Engel, L. W., Young, N. A., Tralka, T. S., Lippman, M. E., O’Brien, S. J., and Joyce, M. J. 1978. Establishment and characterization of a new continuous cell line derived from human breast carcinomas. Cancer Res. 38:3352-3364.
4. Ernster, L. 1967. DT-Diaphorase. Methods Enzymol. 10:309-317.
5. Favaudon, V. 1982. On the mechanism of reductive activation in the mode of action of some anticancer drugs. Biochimie 64:457-475.
6. Hollander, P. M., and Ernster, L. 1975. Studies on the reaction mechanism of DT diaphorase action of dead-end inhibitors and effects of phospholipids. Arch. Biochem. Biophys. 169:560-567.
7. Leighton, J. 1951. A sponge matrix method for tissue culture. Formation of organized aggregates of cells in vitro. J. Natl. Cancer Inst. 12:545-560.
8. Lin, A. J., and Sartorelli, A. 1976. Potential bioreductive alkylating agents. VI. Determination of the relationship between oxidation-reduction potential and antineoplastic activity. Biochem. Pharmacol. 25:206-207.
9. Lin, T.-S., Antonini, I., Cosby, L. A., and Sartorelli, A. C. 1984. 2,3-Dimethyl-1,4-naphthoquinone derivatives as bioreductive alkylating agents with cross-linking potential. J. Med. Chem. 27:813-815.
10. Lind, C., Hochstein, P., and Ernster, L. 1982. DT-diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys. 216:178-185.
11. Miller, G. L. 1959. Protein determination for large numbers of samples. Anal. Chem. 31:964.
12. Moore, H. W. 1977. Bioactivation as a model for drug design. Bioreductive alkylation. Science 197:527-532.
13. Rosenblum, M. L., Vasquez, D. A., Hoshino, T., and Wilson, C. B. 1978. Development of a clonogenic cell assay for human brain tumors. Cancer 41:2305-2314.
14. Smith, M. T. 1985. Quinones as mutagens, carcinogens and anticancer agents: Introduction and overview. J. Toxicol. Environ. Health, 16:665-672.
15. Stenflo, J., Fernlund, P., Egan, W., and Roepstorff, P. 1974. Vitamin K dependent modification of glutamic acid residues in prothrombin. Proc. Natl. Acad. Sci. U.S.A. 71:2730-2733.
16. Talcott, R. E., Rosenblum, M., and Levin, V. A. 1983. Possible role of DT-diaphorase in the bioactivation of antitumor quinones. Biochem. Biophys. Res. Commun. 111:346-351.
17. Thor, H., Smith, M. T., Hartzell, P., Bellomo, G., Jewell, S. A., and Orrenius, S. 1982. The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257:12419-12425.